Decitabine and its prodrug 5′-azacitidine are two widely used DNMT inhibitors for the treatment of patients with various cancers, such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) [17], [18]. Here, DNMT1 is linked to myelodysplastic syndrome.